More data showing one dose of Pfizer vaccine may be enough for individuals who’ve had COVID.
Commentary: One Dose of Pfizer Vaccine May Be Enough for Folks Who’ve Had COVID – HealthDay Original Study: SARS-CoV-2 Antibody Responses in Infection-Naive or Previously Infected Individuals After 1 and 2 Doses of the BNT162b2 Vaccine – JAMA Network Open Related: Perspective | Is one vaccine dose enough if you’ve had COVID? What the science […]
The post More data showing one dose of Pfizer vaccine may be enough for individuals who’ve had COVID. appeared first on Links Medicus.
COVID vaccine boosters: the most important questions.
COVID vaccine boosters: the most important questions – Nature Commentary on Twitter I agree with @nataliexdean: “We just don’t have clear evidence of enough of a loss of efficacy to change our focus or distract from the main goal, which is trying to get as many people first doses” as possible." https://t.co/FEKB4vg0Dz — Sanghyuk […]
The post COVID vaccine boosters: the most important questions. appeared first on Links Medicus.
M-A: SARS-CoV-2 Setting-specific transmission rates – “Households showed the highest transmission rates, with a pooled secondary attack rates of 21.1%”.
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Setting-specific Transmission Rates: A Systematic Review and Meta-analysis – Clinical Infectious Diseases Commentary on Twitter SARS-CoV-2 setting-specific transmission rates: a systematic review and meta-analysis Households highest transmission rates, pooled SAR~21.1%. Contacts at social events~5.9%. Workplaces~1.9%. Age gradient for transmission potential in h/hold context. https://t.co/m27kkDrTgy — Andrew Lee […]
The post M-A: SARS-CoV-2 Setting-specific transmission rates – “Households showed the highest transmission rates, with a pooled secondary attack rates of 21.1%”. appeared first on Links Medicus.
CDC study showed a reduced risk of reinfection with SARS-CoV-2 after covid-19 vaccination.
Reduced Risk of Reinfection with SARS-CoV-2 After COVID-19 Vaccination — Kentucky, May–June 2021 – CDC Morbidity and Mortality Weekly Report Commentaries on Twitter This is non randomized. The two biases are: 1. Behavior among those who got vaccinated likely different than those who don't 2. Likely those who didn't tested more aggressively I would […]
The post CDC study showed a reduced risk of reinfection with SARS-CoV-2 after covid-19 vaccination. appeared first on Links Medicus.
RCT: Safety and immunogenicity of heterologous vs. homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine.
Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial – The Lancet Invited commentary: Optimising SARS-CoV-2 vaccination schedules – The Lancet Related: Another study shows increased immune response with heterologous Oxford-AstraZeneca/mRNA vaccination (several articles on the subject) Commentary on Twitter […]
The post RCT: Safety and immunogenicity of heterologous vs. homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine. appeared first on Links Medicus.
Perspective: Does Treating Sleep Apnea With CPAP Improve Cardiovascular Outcomes or Lower Risk of Atrial Fibrillation? – “Despite numerous flawed observational studies suggesting an association between sleep apnea and cardiovascular outcomes including atr
Does Treating Sleep Apnea With CPAP Improve Cardiovascular Outcomes or Lower Risk of Atrial Fibrillation? – The Skeptical Cardiologist Related: AHA Scientific Statement: Obstructive Sleep Apnea and Cardiovascular Disease. Non-sleepy Obstructive Sleep Apnea: To Treat or Not to Treat? Pro/Con Debate: Should Asymptomatic Patients with Moderate-to-severe OSA be Treated? Obstructive Sleep Apnea in Cardiovascular Disease: […]
The post Perspective: Does Treating Sleep Apnea With CPAP Improve Cardiovascular Outcomes or Lower Risk of Atrial Fibrillation? – “Despite numerous flawed observational studies suggesting an association between sleep apnea and cardiovascular outcomes including atrial fibrillation the gold standard, high-quality RCT data do not clearly show that treatment of sleep apnea with CPAP improves cardiovascular outcomes”. appeared first on Links Medicus.
Fibrotic interstitial lung abnormalities at 1-year follow-up CT after severe COVID-19.
Fibrotic Interstitial Lung Abnormalities at 1-year Follow-up CT after Severe COVID-19 – Radiology Related: Postacute Sequelae of COVID-19 Pneumonia: 6-month Chest CT Follow-up. Commentary on Twitter Data on 1 year outcomes for patients with post-COVID lung fibrosis. Small study, very little clinical information, including on treatment, and I object to the use of the […]
The post Fibrotic interstitial lung abnormalities at 1-year follow-up CT after severe COVID-19. appeared first on Links Medicus.
M-A: Chest radiograph findings in COVID-19.
Systematic review and meta-analysis of chest radiograph (CXR) findings in COVID-19 – Clinical Imaging
The post M-A: Chest radiograph findings in COVID-19. appeared first on Links Medicus.
Clinical Picture: Mucormycosis after COVID-19 in a patient with diabetes.
Mucormycosis after COVID-19 in a patient with diabetes – The Lancet Related: COVID-19 and mucormycosis superinfection: the perfect storm. ECMM/ISHAM recommendations for clinical management of COVID -19 associated mucormycosis in low- and middle-income countries. The “Black Fungus” in India: The Emerging Syndemic of COVID-19–Associated Mucormycosis – careful use of antibiotics and corticosteroids and closely monitoring […]
The post Clinical Picture: Mucormycosis after COVID-19 in a patient with diabetes. appeared first on Links Medicus.
Dexamethasone and tocilizumab treatment considerably reduces the value of C-reactive protein and procalcitonin to detect secondary bacterial infections in COVID-19 patients.
Dexamethasone and tocilizumab treatment considerably reduces the value of C-reactive protein and procalcitonin to detect secondary bacterial infections in COVID-19 patients – Critical Care
The post Dexamethasone and tocilizumab treatment considerably reduces the value of C-reactive protein and procalcitonin to detect secondary bacterial infections in COVID-19 patients. appeared first on Links Medicus.